Egg donation places different demands on a fertility clinic's cryogenic technology than autologous treatment does. Not because the freezing works differently — but because time, distance and a far stricter traceability obligation sit between donor and recipient.
Logistically, a donor programme is a bank, not a treatment chain. Building one means planning capacity, quarantine space, documentation and transport — not just a vitrification protocol.
Regulatory note: egg donation is permitted and practised under differing national frameworks across Europe, including Spain, the Czech Republic and Austria, while it remains prohibited in Germany under the Embryo Protection Act. This article describes the technical requirements for the cryogenic infrastructure such programmes rely on.
Each of these is a requirement on infrastructure, not on the laboratory.
Donor programmes do not grow linearly. They grow in steps. A programme starting with twenty donors a year is often at five times that within three years — with an inventory growing faster than it is drawn down, because not every stored oocyte is used promptly.
Realistic capacity planning accounts for:
For reproductive medicine, Consarctic® supplies the ABV+ series (aluminium cryogenic containers from 4 to 150 litres, designed for vials, straws and bags) and the ABS+ series (stainless steel cryogenic tanks, scalable from a single clinic to a multi-site programme). Both series can be fitted with cassette systems that hold straws in their native format.
In liquid phase, liquid nitrogen can penetrate samples through imperfect closures. Because LN₂ is not a sterile medium, this creates a cross-contamination pathway between samples of different origin. In an inventory holding samples from many different donors, that is not acceptable.
Vapor phase storage above the LN₂ level eliminates that pathway. Its technical challenge is the vertical temperature gradient: upper positions must stay permanently below –130 °C, or recrystallisation begins and undoes the vitrification.
Consarctic® cryogenic tanks address this with the eccentric tank opening: a reduced evaporation surface lowers vapor-phase temperature, flattens the gradient, and simultaneously cuts LN₂ consumption by up to 30 %. The rotatable base shortens retrieval time — significant in an inventory where individual straws are frequently retrieved on demand.
The requirement to identify every sample unambiguously across decades is often treated as a pure software problem. It is not:
All Consarctic systems are manufactured to GMP-compliant standards and certified to EN ISO 13485:2016 and ISO 9001:2015. Documentation is supplied in English and German — no small matter for cross-border programmes.
Where retrieval and transfer happen at different sites, transport decides whether the programme succeeds. The ASR+ dry shipper series from Consarctic® carries vitrified samples with no free liquid nitrogen: the LN₂ is fully absorbed into a porous material.
That yields three practical properties:
Optional integrated data loggers document the temperature profile across the whole journey and close the gap in the chain of custody.
With uninterrupted storage below –130 °C, no biochemical degradation occurs, so storage duration is technically unlimited. The binding constraint is the applicable national legal time limit. What determines quality is not elapsed time but uninterrupted temperature stability.
For reproductive medicine, Consarctic® supplies the ABV+ series (aluminium, 4–150 litres) and the ABS+ series (stainless steel). Both accept straws, vials and bags, use an eccentric tank opening for stable vapor-phase temperatures, and can be fitted with format-matched cassette systems.
Donor samples cannot be released until infectious-disease retesting is complete. Physical separation — ideally in a dedicated tank — prevents mix-ups and keeps release status unambiguously traceable at all times.
With validated dry shippers. The Consarctic® ASR+ series carries no free liquid nitrogen, making it IATA-compliant and orientation-independent, and documents the temperature profile without gaps via an optional integrated data logger.
Specify for three to five years of projected growth rather than current holdings, and separate quarantine from released inventory. Because donor oocytes cannot be replaced, critical holdings should be distributed across at least two independent systems.
What separates a programme that scales from one that stalls on its own logistics is rarely the laboratory. It is capacity planning, quarantine management, traceability and transport.
Building a donor programme, or reaching the limits of your existing cryogenic storage? Consarctic GmbH plans, supplies and qualifies complete cryogenic infrastructure for reproductive medicine facilities, with 24/7 emergency service 365 days a year. Get in touch.